OTCMKTS:PHCEFPharmacielo Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Pharmacielo Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day Range$0.38MA: $0.55▼$0.7652-Week Range N/AVolume174,059 shsAverage Volume64,156 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsHeadlinesSocial Media PharmaCielo Ltd., through its subsidiary, PharmaCielo Colombia Holdings S.A.S., cultivates, processes, produces, and supplies medicinal-grade cannabis oil extracts and related products in Colombia and internationally. It provides cannabidiol and tetrahydrocannabinol-focused cannabis oil extracts for channel distributors, including pharmacies, medical clinics, and cosmetic companies. The company was formerly known as Pan American Cannabis Inc. and changed its name to PharmaCielo Ltd. in September 2014. PharmaCielo Ltd. is headquartered in Toronto, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Pharmacielo. Previous Next 3.7 Community Rank Outperform VotesPharmacielo has received 44 “outperform” votes. (Add your “outperform” vote.)Underperform VotesPharmacielo has received 15 “underperform” votes. (Add your “underperform” vote.)Community SentimentPharmacielo has received 74.58% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Pharmacielo and other stocks. Vote “Outperform” if you believe PHCEF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PHCEF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldPharmacielo does not currently pay a dividend.Dividend GrowthPharmacielo does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Pharmacielo insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.74 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:PHCEF Previous Symbol CUSIPN/A CIKN/A Webwww.pharmacielo.com Phone647-560-4640Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees49 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable OTC:PHCEF Rates by TradingView Receive PHCEF News and Ratings via Email Sign-up to receive the latest news and ratings for PHCEF and its competitors with MarketBeat's FREE daily newsletter. Pharmacielo (OTCMKTS:PHCEF) Frequently Asked Questions Has Pharmacielo been receiving favorable news coverage? Headlines about PHCEF stock have trended extremely negative recently, according to InfoTrie Sentiment. The research group scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Pharmacielo earned a media sentiment score of -5.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the next several days. View the latest news aboutPharmacielo. Who are some of Pharmacielo's key competitors? Some companies that are related to Pharmacielo include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannabis Science (CBIS), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF) and Cipher Pharmaceuticals (CPHRF). View all competitors. Who are Pharmacielo's key executives? Pharmacielo's management team includes the following people: Mr. Scott Laitinen, CFO & DirectorMr. David Attard, CEO, Pres & DirectorDr. Delon Human M.B.Ch.B., M.Prax.Med, MFGP, DCH, MBA, Global Head of Health & Innovation, Vice Chairman & Chairman of Medical & Scientific Advisory BoardMr. Marcelo Antunes De Siqueira, Chief Operating Officer (Nursery & Propagation Centre)Mr. David Gordon, Chief Corp. Officer & Director What is Pharmacielo's stock symbol? Pharmacielo trades on the OTCMKTS under the ticker symbol "PHCEF." How do I buy shares of Pharmacielo? Shares of PHCEF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Pharmacielo's official website? The official website for Pharmacielo is www.pharmacielo.com. How can I contact Pharmacielo? The company can be reached via phone at 647-560-4640. This page was last updated on 6/5/2020 by MarketBeat.com Staff
